Godsey & Gibb Inc’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
LMFP
AIM
FWIA
DLA
Godsey & Gibb Inc's BMY Position: Q2 2026 in Review
Godsey & Gibb Inc held its Bristol-Myers Squibb (BMY) position steady in Q2 2026 at 455 shares worth $26.2K. The position accounts for ﹤0.01% of the portfolio, ranked #216.
Godsey & Gibb Inc first reported a position in BMY in Q2 2019 and has held it in 21 quarters since. The position peaked at $326K in Q2 2020. 796 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Godsey & Gibb Inc held 455 shares of Bristol-Myers Squibb worth $26.2K as of Q2 2026.
- Godsey & Gibb Inc left its Bristol-Myers Squibb share count unchanged in Q2 2026.
- Bristol-Myers Squibb made up ﹤0.01% of Godsey & Gibb Inc's portfolio in Q2 2026, its #216 holding.
- Godsey & Gibb Inc first reported a position in Bristol-Myers Squibb in Q2 2019 and has held it in 21 quarters since.
- Godsey & Gibb Inc's Bristol-Myers Squibb position peaked at $326K in Q2 2020.
- 796 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Godsey & Gibb Inc's 13F filing for Q2 2026, filed 13 Jul 2026.